Literature DB >> 21633073

Early determinants of type 1 diabetes: experience from the BABYDIAB and BABYDIET studies.

Sandra Hummel1, Anette G Ziegler.   

Abstract

Type 1 diabetes is an immune-mediated disorder that results from progressive destruction of the islet β cells. A genetic susceptibility for the development of islet autoimmunity and type 1 diabetes is well documented, and an environmental influence is assumed. Prospective studies from birth have shown that islet autoimmunity occurs very early in life, which implies that fetal or postnatal environmental factors may program the development of islet autoimmunity. In this overview, results from the BABYDIAB study, a prospective study from birth on the natural history of type 1 diabetes, and the BABYDIET study, a dietary intervention study, are discussed with a focus on the role of a diabetes environment in utero and the role of early gluten exposure on islet autoimmunity risk in children.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21633073     DOI: 10.3945/ajcn.110.000646

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  11 in total

Review 1.  Immune Mechanisms and Pathways Targeted in Type 1 Diabetes.

Authors:  Laura M Jacobsen; Brittney N Newby; Daniel J Perry; Amanda L Posgai; Michael J Haller; Todd M Brusko
Journal:  Curr Diab Rep       Date:  2018-08-30       Impact factor: 4.810

2.  Strength in Numbers: Opportunities for Enhancing the Development of Effective Treatments for Type 1 Diabetes-The TrialNet Experience.

Authors:  Carla J Greenbaum; Cate Speake; Jeffrey Krischer; Jane Buckner; Peter A Gottlieb; Desmond A Schatz; Kevan C Herold; Mark A Atkinson
Journal:  Diabetes       Date:  2018-05-16       Impact factor: 9.461

3.  Predicting progression to type 1 diabetes from ages 3 to 6 in islet autoantibody positive TEDDY children.

Authors:  Laura M Jacobsen; Helena E Larsson; Roy N Tamura; Kendra Vehik; Joanna Clasen; Jay Sosenko; William A Hagopian; Jin-Xiong She; Andrea K Steck; Marian Rewers; Olli Simell; Jorma Toppari; Riitta Veijola; Anette G Ziegler; Jeffrey P Krischer; Beena Akolkar; Michael J Haller
Journal:  Pediatr Diabetes       Date:  2019-01-29       Impact factor: 3.409

Review 4.  Environmental trigger(s) of type 1 diabetes: why so difficult to identify?

Authors:  Kjersti S Rønningen
Journal:  Biomed Res Int       Date:  2015-03-25       Impact factor: 3.411

Review 5.  A1 beta-casein milk protein and other environmental pre-disposing factors for type 1 diabetes.

Authors:  J S J Chia; J L McRae; S Kukuljan; K Woodford; R B Elliott; B Swinburn; K M Dwyer
Journal:  Nutr Diabetes       Date:  2017-05-15       Impact factor: 5.097

Review 6.  The Challenges of Identifying Environmental Determinants of Type 1 Diabetes: In Search of the Holy Grail.

Authors:  Sonia Butalia; Gilaad G Kaplan; Bushra Khokhar; Sydney Haubrich; Doreen M Rabi
Journal:  Diabetes Metab Syndr Obes       Date:  2020-12-09       Impact factor: 3.168

7.  Early childhood infections and the risk of islet autoimmunity: the Diabetes Autoimmunity Study in the Young (DAISY).

Authors:  Janet K Snell-Bergeon; Jennifer Smith; Fran Dong; Anna E Barón; Kathy Barriga; Jill M Norris; Marian Rewers
Journal:  Diabetes Care       Date:  2012-10-05       Impact factor: 19.112

Review 8.  Recent lessons learned from prevention and recent-onset type 1 diabetes immunotherapy trials.

Authors:  Teodora P Staeva; Lucienne Chatenoud; Richard Insel; Mark A Atkinson
Journal:  Diabetes       Date:  2013-01       Impact factor: 9.461

Review 9.  Animal models to study gluten sensitivity.

Authors:  Eric V Marietta; Joseph A Murray
Journal:  Semin Immunopathol       Date:  2012-05-11       Impact factor: 11.759

10.  Metabolic alterations in immune cells associate with progression to type 1 diabetes.

Authors:  Partho Sen; Alex M Dickens; María Asunción López-Bascón; Tuomas Lindeman; Esko Kemppainen; Santosh Lamichhane; Tuukka Rönkkö; Jorma Ilonen; Jorma Toppari; Riitta Veijola; Heikki Hyöty; Tuulia Hyötyläinen; Mikael Knip; Matej Orešič
Journal:  Diabetologia       Date:  2020-02-11       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.